Table 1 Clinicopathological comparison between ALK gene rearrangement-positive and -negative pulmonary adenocarcinoma
From: ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy
Variable | Patient total (n = 268) | ALK rearrangement | P value | |
|---|---|---|---|---|
Positive (n = 26) | Negative (n = 242) | |||
Age | Â | Â | Â | 0.006 |
 Median | 63 | 59.5 | 63 |  |
 Range | 24–90 | 24–90 | 24–89 |  |
Gender | Â | Â | Â | 0.036 |
 Male | 117 (43.7) | 6 (23.1) | 111 (45.8) |  |
 Female | 151 (56.3) | 20 (76.9) | 131 (54.2) |  |
Smoking | Â | Â | Â | 0.032 |
 Never smoking | 202 (75.4) | 24 (92.3) | 177 (73.1) |  |
 Smoking | 66 (24.6) | 2 (7.7) | 65 (26.9) |  |
Stage | Â | Â | Â | 0.540 |
 Early (I–II) | 120 (44.6) | 10 (38.5) | 110 (55) |  |
 Advanced (III–IV) | 148 (45.4) | 16 (61.5) | 132 (54.5) |  |